Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Arthur J. Gallagher Expands In Australia With P2 Group Buyout

Published 06/17/2019, 10:46 PM
Updated 07/09/2023, 06:31 AM

Arthur J. Gallagher & Co. (NYSE:AJG) recently acquired P2 Group in its effort to grow outside the United States. The terms of the transaction have not been revealed.

Hawthorn, Victoria-based P2 Group was founded in 2003. The company helps employers manage occupational health and lower the risk of worker injuries and WorkCover claims. Addition of P2 Group to Arthur J. Gallagher’s portfolio will help boost its retail brokerage division's Workplace Risk Practice's footprint as well as consolidate its presence in Victoria. The acquisition will also enhance cross-selling opportunities for the acquirer.

Arthur J. Gallagher is one of the top five global brokers. The company’s revenues are geographically diversified with strong domestic and international operations. Over some time, the company has been actively pursuing acquisitions outside the United States to grow its international operations.

In the first quarter of 2019, international operations across Australia, Bermuda, Canada, the Caribbean, New Zealand and the United Kingdom generated 26% of the revenues. Given the number and size of its non-U.S. acquisitions, the Zacks Rank #3 (Hold) insurance broker expects international contribution to total revenues to increase. Its recent acquisitions have helped it expand in New Zealand, Australia and United Kingdom.

Arthur J. Gallagher remains focused on its long-term growth strategies of delivering organic revenue growth and pursuing strategic mergers and acquisition. It is also focused on productivity improvements and quality enhancements that should help it post sturdy numbers in the future.

Shares of Arthur J. Gallagher have gained 10.5% quarter to date, in line with the industry’s rise The company’s policy to ramp up its growth profile and capital position should continue to drive share price higher.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .



There have been a host of acquisitions in the insurance space of late given the significant capital available. Brown & Brown of Kentucky, Inc., a subsidiary of Brown & Brown, Inc. (NYSE:BRO) , acquired United Development Systems, Inc. The Hartford Financial Services Group, Inc. (NYSE:HIG) acquired The Navigators Group, Inc.

A Stock to Consider

A better-ranked insurer is eHealth, Inc. (NASDAQ:EHTH) , sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

eHealth provides private health insurance exchange services to individuals, families, and small businesses in the United States and China. The company delivered positive earnings surprise of 512.20% in the last reported quarter.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>



eHealth, Inc. (EHTH): Free Stock Analysis Report

Arthur J. Gallagher & Co. (AJG): Free Stock Analysis Report

Brown & Brown, Inc. (BRO): Free Stock Analysis Report

The Hartford Financial Services Group, Inc. (HIG): Free Stock Analysis Report
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.